CDW Médical: what changed
CDW Médical
Largest movements
- Cash +€83,734
up €83,734 (+106%), from €78,949 to €162,683
mainly Net result for the year (+€95,932) and Receivables within one year (+€11,031)
- Deferred charges and accrued income +€12,767
up €12,767 (+1,560%), from €818 to €13,585
- Receivables within one year -€11,031
down €11,031 (-84.5%), from €13,054 to €2,023
of which Trade receivables: -€13,054
- Profit (loss) carried forward +€95,932
new in 2025: €95,932
- Tax, wage and social debts -€10,217
no longer reported in 2025 (was €10,217)
- Trade debts -€2,561
down €2,561 (-71.7%), from €3,571 to €1,010
- Gross operating margin +€13,360
up €13,360 (+12.0%), from €110,919 to €124,279
- Taxes -€5,057
down €5,057 (-15.7%), from €32,217 to €27,160
- Financial charges -€1,290
down €1,290 (-70.5%), from €1,831 to €541
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €94,380 | €179,205 | +€84,824 | +89.9% |
| Fixed assets | 21/28 | €1,559 | €914 | -€646 | -41.4% |
| Tangible fixed assets | 22/27 | €1,559 | €914 | -€646 | -41.4% |
| Furniture and vehicles | 24 | €1,559 | €914 | -€646 | -41.4% |
| Current assets | 29/58 | €92,821 | €178,291 | +€85,470 | +92.1% |
| Amounts receivable within one year | 40/41 | €13,054 | €2,023 | -€11,031 | -84.5% |
| Trade receivables | 40 | €13,054 | - | -€13,054 | |
| Other amounts receivable | 41 | - | €2,023 | +€2,023 | |
| Cash at bank and in hand | 54/58 | €78,949 | €162,683 | +€83,734 | +106% |
| Deferred charges and accrued income | 490/1 | €818 | €13,585 | +€12,767 | +1,560% |
| Total equity and liabilities | 10/49 | €94,380 | €179,205 | +€84,824 | +89.9% |
| Equity | 10/15 | €80,593 | €176,525 | +€95,932 | +119% |
| Contributions | 10/11 | €4,100 | €4,100 | = | 0.0% |
| Reserves | 13 | €76,493 | €76,493 | = | 0.0% |
| Distributable reserves | 133 | €76,493 | €76,493 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €95,932 | +€95,932 | |
| Amounts payable | 17/49 | €13,788 | €2,679 | -€11,108 | -80.6% |
| Amounts payable within one year | 42/48 | €13,788 | €2,679 | -€11,108 | -80.6% |
| Trade debts | 44 | €3,571 | €1,010 | -€2,561 | -71.7% |
| Suppliers | 440/4 | €3,571 | €1,010 | -€2,561 | -71.7% |
| Taxes, remuneration and social security | 45 | €10,217 | - | -€10,217 | |
| Taxes | 450/3 | €10,217 | - | -€10,217 | |
| Other amounts payable | 47/48 | - | €1,670 | +€1,670 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €378 | €646 | +€268 | +70.9% |
| Gross operating margin | 9900 | €110,919 | €124,279 | +€13,360 | +12.0% |
| Operating profit (loss) | 9901 | €110,541 | €123,633 | +€13,092 | +11.8% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €1,831 | €541 | -€1,290 | -70.5% |
| Recurring financial charges | 65 | €1,831 | €541 | -€1,290 | -70.5% |
| Profit (loss) for the period before taxes | 9903 | €108,710 | €123,092 | +€14,382 | +13.2% |
| Income taxes | 67/77 | €32,217 | €27,160 | -€5,057 | -15.7% |
| Profit (loss) for the period | 9904 | €76,493 | €95,932 | +€19,440 | +25.4% |
| Profit (loss) for the period to be appropriated | 9905 | €76,493 | €95,932 | +€19,440 | +25.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.